147 related articles for article (PubMed ID: 16527609)
1. The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma.
Corzo C; Corominas JM; Tusquets I; Salido M; Bellet M; Fabregat X; Serrano S; Solé F
Cancer Genet Cytogenet; 2006 Mar; 165(2):151-6. PubMed ID: 16527609
[TBL] [Abstract][Full Text] [Related]
2. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
[TBL] [Abstract][Full Text] [Related]
3. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
4. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
Mendelin J; Grayson M; Wallis T; Visscher DW
Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
[TBL] [Abstract][Full Text] [Related]
5. MYC amplification and TERT expression in breast tumor progression.
Bodvarsdóttir SK; Steinarsdóttir M; Hilmarsdóttir H; Jónasson JG; Eyfjörd JE
Cancer Genet Cytogenet; 2007 Jul; 176(2):93-9. PubMed ID: 17656250
[TBL] [Abstract][Full Text] [Related]
6. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R
Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of c-myc proto-oncogene in primary human breast carcinomas.
Pavelic ZP; Steele P; Preisler HD
Anticancer Res; 1991; 11(4):1421-7. PubMed ID: 1660688
[TBL] [Abstract][Full Text] [Related]
9. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array.
Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ
Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174
[TBL] [Abstract][Full Text] [Related]
10. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics.
Visscher DW; Wallis T; Awussah S; Mohamed A; Crissman JD
Genes Chromosomes Cancer; 1997 Jan; 18(1):1-7. PubMed ID: 8993975
[TBL] [Abstract][Full Text] [Related]
12. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
[TBL] [Abstract][Full Text] [Related]
13. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
14. Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.
Rao JY; Apple SK; Jin Y; Lin S; Nieberg RK; Hirtschowitz SL
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):175-9. PubMed ID: 10698478
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray.
Shin SJ; Hyjek E; Early E; Knowles DM
Int J Surg Pathol; 2006 Oct; 14(4):279-84. PubMed ID: 17041191
[TBL] [Abstract][Full Text] [Related]
16. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution.
Buerger H; Mommers EC; Littmann R; Simon R; Diallo R; Poremba C; Dockhorn-Dworniczak B; van Diest PJ; Boecker W
J Pathol; 2001 Jun; 194(2):165-70. PubMed ID: 11400144
[TBL] [Abstract][Full Text] [Related]
17. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
18. Oncogene amplification in breast cancer.
Donovan-Peluso M; Contento AM; Tobon H; Ripepi B; Locker J
Am J Pathol; 1991 Apr; 138(4):835-45. PubMed ID: 1849359
[TBL] [Abstract][Full Text] [Related]
19. The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer.
Hyun CL; Lee HE; Kim KS; Kim SW; Kim JH; Choe G; Park SY
J Clin Pathol; 2008 Mar; 61(3):317-21. PubMed ID: 17761736
[TBL] [Abstract][Full Text] [Related]
20. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
